Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

Stemtech International, Inc. provides dietary supplements. Its products include Natural Stem Cell Solution, SE3, SE2, StemEnhance, StemFlo, ST-5 with MigraStem, StemSport, DermaStem, StemPets, and StemEquine. The company was founded by Christian Drapeau and Ray C. Carter Jr. in 2005 and is headquartered in Pembroke Pines, FL.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

GlyTech, Inc. engages in providing drug discovery and biologics services and pharmaceutical ingredients. The firm conducts drug discovery utilizing its platform technologies and provides innovative biologics and pharmaceutical ingredients based on the chemical synthetic methods for proteins and peptides through glyco-science and -technology. GlyTech offers custom synthesis services, research and development collaborations, and deal structures: upfront, milestones and royalties. The company was founded on April 2, 2012 and is headquartered in Kyoto, Japan.

Shenyang Kesi High-Tech Co., Ltd., established on 2006-10-19, Business scope includes extraction and processing of natural products;new material,New process development;Technology Consulting,Transfer of scientific and technological achievements(Except for the operations restricted by the laws and regulations of the above business items).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Ezaki Glico Co. is a food company headquartered in Osaka, Japan. It has 11 business locations and 23 group companies in Japan, and 12 subsidiaries in nine countries. Ezaki Glico operates a total of 19 plants and has 5,210 employees all over the world. Since the launch in 1922 of the nutritious and fortified Glico caramel in its distinctive red box, the business activities of Ezaki Glico have adhered to the corporate philosophy of "Enhancing Public Health Through Food." Upon the 70th anniversary of Ezaki Glico in 1992, this same spirit and dedication have been incorporated into the revised corporate philosophy of "A Wholesome Life in the Best of Taste." Glico caramel – the company's first product – incorporates the innovative creativeness of Mr. Riichi Ezaki, the company's founder. From the beginning, all personnel working for the company have been dedicated to further enhancing people's health and quality of life. This has led to the expansion of business lines beyond confectionery to include ice cream products, processed foods, desserts, milk products, baby formula, food ingredients, and ingredients for cosmetic and health products.

Supranaturals is a manufacturer of nutraceutical products. Their products include liquids, powders, and capsules, personal care, CBD and hemp products, lotions, creams, shave oils, tablets, essential oils, chewable tablets, soft gels, and stick packs.

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

JBKLAB Co. Ltd. manufactures cyanidine polysaccharide nano complex. The firm’s offers functional raw materials for drug (raw materials, new drug pipeline) and health functional food, drug and supplement for companion animal and phythochemical fusion health functional food. The company was founded in March 2008 and is headquartered in Gyeonggi-do, South-Korea.

Accelerating new ideas testing by building software products using no-code technologies and saving thousands of dollars in between.

Beijing Leili Marine Biological New Industry Co., Ltd., established on 1993-02-01, The scope of business includes the production of compound fertilizers,organic fertilizer,slow release fertilizer,water soluble fertilizer,soil conditioner,microbial fertilizer,fertilizer synergist,Seaweed Biological Products,Fucoidan,Fucoxanthin,seaweed liquid fertilizer,Seaweed Extract,Feed additives,plant nutrition regulator;Seaweed products,compound fertilizer,Medium element fertilizer,trace element fertilizer,biological fertilizer,microbial fertilizer,Alginate Fertilizer,Fucoidan seaweed food additive,Beverage Additives,natural plant protectant,Research and development of seaweed active substance extraction products;Sell ​​self-produced products;Technical Services,Technology Promotion,technology transfer,technical consulting;Organize cultural exchange activities(Excluding show agency);Import and export,Technology Import and Export,Agent import and export.(Commodities that do not involve state trade management,Application procedures for relevant regulations of the Anglo-Chinese government involving commodities under quota license management)(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Riken Vitamin Co., Ltd. engages in the production and sale of consumer and commercial foods, processed food ingredients, food and chemical improvers, and vitamins. It operates through the following segments: Domestic Food, Domestic Chemicals and Overseas. The Domestic Food segment handles the household food products, commercial food products, and food processing raw materials. The Domestic Chemicals segment manufactures chemical modifiers and feed additives. The Overseas segment provides healthcare products, chemical improving agents, marine processed foods, and frozen vegetables. The company was founded on August 27, 1949 and is headquartered in Tokyo, Japan.